Document ID: EPA-HQ-OPPT-2003-0010-0088
Agency: epa
Document Type: Notice
Title: TSCA Chemical Testing; Receipt of Test Data
Posted Date: 2006-08-02T12:11:17Z

[Federal Register: August 2, 2006 (Volume 71, Number 148)]
[Notices]               
[Page 43763-43764]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02au06-75]                         

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2003-0006; FRL-8078-7]

 
TSCA Chemical Testing; Receipt of Test Data

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's receipt of test data on In Vitro 
Dermal Absorption Rate Testing of certain chemicals of interest to the 
Occupational Safety and Health Administration (OSHA). EPA received data 
on the following chemicals: Dipropylene glycol methyl ether (DPGME) 
(CAS No. 34590-94-8); naphthalene (CAS No. 91-20-3); diphenylamine 
(DPA) (CAS No. 122-39-4); 1-nitropropane (CAS No. 108-03-2); 2-
nitropropane (CAS No. 79-46-9); isophorone (CAS No. 78-59-1); p-
nitrochlorobenzene (CAS No. 100-00-5); and benzyl chloride (CAS No. 
100-44-7). These data were submitted pursuant to a test rule issued by 
EPA under section 4 of the Toxic Substances Control Act (TSCA).

FOR FURTHER INFORMATION CONTACT: Colby Lintner, Regulatory Coordinator, 
Environmental Assistance Division (7408M), Office of Pollution 
Prevention and Toxics, Environmental Protection Agency, 1200 
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: 
(202) 554-1404; e-mail address: TSCA-Hotline@epa.gov.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general. This action may, 
however, be of interest to those persons who are concerned about data 
on health and/or environmental effects and other characteristics of 
this chemical. Since other entities may also be interested, the Agency 
has not attempted to describe all the specific entities that may be 
affected by this action. If you have any questions regarding the 
applicability of this action to a particular entity, consult the person 
listed under FOR FURTHER INFORMATION CONTACT.

B. How Can I Get Copies of this Document and Other Related Information?

    1. Docket. EPA has established a docket for this action under 
docket identification (ID) number EPA-HQ-OPPT-2003-0006. Publicly 
available docket materials are available electronically at http://www.regulations.gov
 or in hard copy at the OPPT Docket, EPA Docket 

Center (EPA/DC), EPA West, Room B102, 1301 Constitution Ave., NW., 
Washington, DC. The EPA Docket Center Public Reading Room is open from 
8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal 
holidays. The telephone number for the Public Reading Room is (202) 
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
    2. Electronic access. You may access this Federal Register document

[[Page 43764]]

electronically through the EPA Internet under the ``Federal Register'' 
listings at http://www.epa.gov/fedrgstr/.

II. Test Data Submissions

    Section 4(d) of TSCA requires EPA to publish a notice in the 
Federal Register reporting the receipt of test data submitted pursuant 
to test rules promulgated under section 4(a) within 15 days after these 
data are received by EPA.
    1. Test data for DPGME were submitted by the DPGME Dermal 
Absorption Task Group of the American Chemistry Council's Ethylene and 
Propylene Glycol Ethers Panel and received by EPA on February 22, 2006. 
The submission includes a final report titled ``Dipropylene Glycol 
Methyl Ether: In Vitro Dermal Absorption Rate Testing''. (See Document 
ID No. EPA-HQ-OPPT-2003-0006-0325).
    2. Test data for naphthalene were submitted on behalf of the 
American Chemistry Council Naphthalene Panel's In Vitro Dermal 
Absorption Rate Testing Consortium and received by EPA on March 20, 
2006. The submission includes a final report titled ``Naphthalene: In 
Vitro Dermal Absorption Rate Testing.'' (See Document ID No. EPA-HQ-
OPPT-2003-0006-0328).
    3. Test data for DPA were submitted by Chemtura Corporation and 
received by EPA on March 29, 2006. The submission includes a final 
report titled ``Determination of the In Vitro Absorption Rate of 
Diphenylamine.'' (See Document ID No. EPA-HQ-OPPT-2003-0006-0330).
    4. Test data for 1-nitropropane were submitted by the Angus 
Chemical Company, a wholly owned subsidiary of the Dow Chemical 
Company, and received by EPA on October 13, 2005. The submission 
includes a final report titled ``1-Nitropropane: In Vitro Dermal 
Absorption Rate Testing.'' (See Document ID No. EPA-HQ-OPPT-2003-0006-
0343).
    5. Test data for 2-nitropropane were submitted by the Angus 
Chemical Company, a wholly owned subsidiary of the Dow Chemical 
Company, and received by EPA on October 13, 2005. The submission 
includes a final report titled ``2-Nitropropane: In Vitro Dermal 
Absorption Rate Testing.'' (See Document ID No. EPA-HQ-OPPT-2003-0006-
0344).
    6. Test data for isophorone were submitted by the Isophorone Dermal 
Absorption Task Group of the American Chemistry Council and received by 
EPA on February 14, 2006. An amended report was also received by EPA on 
April 17, 2006. The submissions include an original and amended final 
study report titled: ``Percutaneous Absorption and Cutaneous 
Disposition of [14C]-Isophorone In Vitro in Human Skin.'' 
(See Document ID No. EPA-HQ-OPPT-2003-0006-0346).
     7. Test data for p-nitrochlorobenzene were submitted by ATK 
Thiokol and received by EPA on May 25, 2006. The submission includes a 
final study report titled: ``p-Nitrochlorobenzene: In Vitro Dermal 
Absorption Rate Testing.`` (See Document ID No. EPA-HQ-OPPT-2003-0006-
0351).
    8. Test data for benzyl chloride were submitted by LANXESS 
Corporation and Ferro Corporation and received by EPA on May 30, 2006. 
The submission includes a final study report titled: ``Benzyl Chloride: 
In Vitro Dermal Absorption Rate Testing.'' (See Document ID No. EPA-HQ-
OPPT-2003-0006-0352).
    These chemical substances are used in a wide variety of 
applications as industrial solvents, which may result in exposures of a 
substantial number of workers as described in the support document for 
the proposed rule (64 FR 31074, June 9, 1999, Table 3-Exposure 
Information for Chemical Substances).
    EPA has initiated its review and evaluation process for these 
submissions. At this time, the Agency is unable to provide any 
determination as to the completeness of these submissions.

    Authority: 15 U.S.C. 2603.

List of Subjects

    Environmental protection, Hazardous substances.

    Dated: July 20, 2006.
 James Willis,
Director, Chemical Control Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. E6-12340 Filed 8-1-06; 8:45 am]

BILLING CODE 6560-50-S